Vital residues-orientated rational design of butenolide inhibitors targeting Of ChtI

• Published in: Medicinal chemistry research 2024, Vol.33 (5), p.740-747
• Main Authors: Han, Qing, Zi, Yun-Jiang, Feng, Tian-Yu, Wu, Nan, Zou, Ren-Xuan, Zhang, Jing-Yu, Zhang, Ru-Lei, Yang, Qing, Duan, Hong-Xia
• Format: Article
• Language: English
• Subjects: Benzene; Binding; Biochemistry; Biomedical and Life Sciences; Biomedicine; Bioorganic Chemistry; Brief Report; Enzymatic activity; Hydrogen bonds; Inhibitors; Inorganic Chemistry; Lead compounds; Medicinal Chemistry; Molecular modelling; Nitrogen dioxide; Pharmacology/Toxicology; Residues
• ISSN: 1054-2523; 1554-8120
• DOI: 10.1007/s00044-024-03211-5

An effective approach for discovering small molecular inhibitors is the residues-oriented strategy based on enzyme analysis. In this study, we employed a rational approach to design and synthesize a library of butenolide analogues ( Ia-f and IIa-f ) targeting Trp107, utilizing reported piperonyl butenolide as lead compound. Notably, the most compounds IIa-f (R 2  = NO 2 ) exhibited slightly higher inhibitory potency against Of ChtI compared to compounds Ia-f (R 2  = Br). Molecular mechanism studies unveiled a crucial hydrogen bond interaction between the NO 2 group and Trp107, explaining the enhanced binding affinities. Compounds IIe and IIf , both bearing NO 2 on the benzene ring at the R 2 position, displayed the highest inhibitory activity, with K i values of 0.87 and 0.68  μ M, respectively. Our findings highlight the potential of designing inhibitors with high enzymatic activity by structurally optimizing compounds based on the distinct interaction modes with crucial residues in the binding cavity of Of ChtI.